
[Federal Register: April 9, 2009 (Volume 74, Number 67)]
[Proposed Rules]               
[Page 16160-16161]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09ap09-18]                         

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 589

[Docket No. FDA-2002-N-0031] (formerly Docket No. 2002N-0273)
RIN 0910-AF46

 
Substances Prohibited From Use in Animal Food or Feed; Final 
Rule: Proposed Delay of Effective Date

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice of proposed delay of effective date.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) is seeking public 
comment on a contemplated delay of 60 days in the effective date of the 
rule entitled ``Substances Prohibited From Use in Animal Food or 
Feed,'' published in the Federal Register on

[[Page 16161]]

April 25, 2008 (73 FR 22720). That rule established measures to further 
strengthen existing safeguards against bovine spongiform encephalopathy 
(BSE). FDA has become aware that some affected persons, particularly 
those in the rendering industry, are experiencing difficulties 
modifying their operations to comply with the new requirements 
contained in the April 25, 2008 final rule and, therefore, may not be 
in full compliance by the April 27, 2009, effective date. Accordingly, 
the FDA is proposing this action to delay the effective date of the 
April 25, 2008, final rule for 60 days until June 26, 2009. FDA is 
providing 7 days for public comment solely on the question of whether 
to delay the effective date.

DATES:  Comments must be received on or before April 16, 2009.

ADDRESSES:  You may submit comments, identified by [Docket No. FDA-
2002-N-0031], by any of the following methods:
Electronic Submissions
    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
Written Submissions
    Submit written submissions in the following ways:
     FAX: 301-827-6870.
     Mail/Hand delivery/Courier (for paper, disk, or CD-ROM 
submissions): Division of Dockets Management (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
    To ensure more timely processing of comments, FDA is no longer 
accepting comments submitted to the agency by e-mail. FDA encourages 
you to continue to submit electronic comments by using the Federal 
eRulemaking Portal, as described previously, in the ADDRESSES portion 
of this document under Electronic Submissions.
    Instructions: All submissions received must include the agency name 
and docket number and Regulatory Information Number (RIN 0910-AF46) for 
this rulemaking. All comments received may be posted without change to 
http://www.regulations.gov, including any personal information 
provided.
    Docket: For access to the docket to read background documents or 
comments received, go to http://www.regulations.gov and insert the 
docket number, found in brackets in the heading of this document, into 
the ``Search'' box and follow the prompts and/or go to the Division of 
Dockets Management, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT:  Burt Pritchett, Center for Veterinary 
Medicine (HFV-222), Food and Drug Administration, 7519 Standish Pl., 
Rockville, MD 20855, 240-453-6860, e-mail: burt.pritchett@fda.hhs.gov.

    Dated: April 6, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-8127 Filed 4-6-09; 4:15 pm]

BILLING CODE 4160-01-S
